Repligen stock price target reaffirmed at $225 by UBS on growth outlook

🌐 Investing.com (Cyprus) —
Repligen stock price target reaffirmed at $225 by UBS on growth outlook

AI Summary

UBS reaffirmed its $225 price target for Repligen, citing a growth outlook. The headline does not provide additional details about the analyst’s assumptions or the company’s performance.

Markets Health Repligen UBS price target growth outlook biotechnology equities

Read original source →